Plasma Concentration Studies
Mod GRF 1-29 + Ipamorelin
Modified GRF + Ipamorelin
CJC/Ipa Blend
A strategic peptide combination engineered to enhance gh release through synchronized GHRH and ghrelin receptor activation in experimental research models. Premium Research Peptide.
Third Party Tested by Freedom Diagnostics
Technical specifications
Synergistic GH release
Dual-pathway activation
Pulsatile pattern preserved
Peer-reviewed research
Journal of Clinical Endocrinology & Metabolism
Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-...
2006 • DOI: 10.1210/jc.2...
PMID: 16352683
Teichman SL, Neale A, Lawrence B et...
European Journal of Endocrinology
Ipamorelin, the first selective growth hormone secretagogue
1998 • DOI: 10.1530/eje...
PMID: 9849822
Raun K, Hansen BS, Johansen NL et al.
Journal of Clinical Endocrinology & Metabolism
On the actions of the growth hormone-releasing hexapeptide, GHRP
1991
PMID: 1919399
Bowers CY, Reynolds GA, Durham D e
Translational Andrology and Urology
A Review of Growth Hormone Secretagogues
2018 • DOI: 10.21037/ta....
PMID: 30186644
Sigalos JT, Pastuszak AW
Journal of Clinical Endocrinology & Metabolism
Effects of Growth Hormone and Its Secretagogues on Bone
1998
PMID: 9851737
Svensson J, Ohlsson C, Jansson JO et...
Journal of Clinical Endocrinology & Metabolism
Once-Daily Administration of CJC-1295, a Long-Acting Growth Hormone-Releasing Hormone (GHR...
2006 • DOI: 10.1210/jc.2...
PMID: 16670169
Alba M, Fintini D, Sagazio A et al.
